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Introduction
The human disease cerebral cavernous malformation (CCM) is
characterized by abnormal vascular structures mostly localized in
the brain. Germline mutation in any of three independent genes,
CCM1, CCM2 or CCM3, causes the inherited form of the disease
(Plummer et al., 2005; Labauge et al., 2007), whereas local somatic
mutation of these genes might induce the sporadic form (Limaye
et al., 2009). The most dangerous clinical symptom in CCM is
hemorrhagic stroke. Additionally, hemosiderin deposits in the
tissue adjacent to lesions strongly suggest continuous blood leakage
from the abnormal vessels, which could account for epilepsy and
other neurological symptoms (Rigamonti et al., 1988).
Histological and ultrastructural analyses reveal that
malformations consist of clusters of dilated vascular sacs (Wong et
al., 2000), with endothelial cells (ECs) lacking both tight junctions
(TJs) (Clatterbuck et al., 2001) and the support of astrocyte foot
processes at the ablumenal aspect of vessels (Clatterbuck et al.,
2001). Fibronectin, growth factors (VEGF, bFGF, TGFa), and
smooth muscle actin are abundant in the ECs of lesions, whereas
laminin and collagen IV are reduced (Hallmann et al., 2005),
reminiscent of an immature or angiogenic situation (Kilic et al.,
2000). Together, these observations strongly suggest that defects in
lumen formation and vascular fragility are key features of CCM
lesions.
Regulation of vascular permeability by CCM1 and CCM2 has
been analyzed both in vitro and in vivo, and is associated with the
organization of cell-cell junctions (Glading et al., 2007; Whitehead
et al., 2009). In particular, CCM1 acts as an effector of the small
GTPase Rap1, by enhancing the stability of endothelial adherens
junctions (AJs).
The presence of vascular malformations might also contribute
to vascular fragility. Abnormal blood flow generates turbulence and
alterations in shear stress that can induce vascular rupture. The
mechanism by which the absence of CCM proteins produces
vascular malformation remains largely unexplored (Whitehead et
al., 2004), possibly because of the gaps that still remain to be filled
in our understanding of the pathways that direct vascular lumen
formation (Iruela-Arispe and Davis, 2009). Kamei and co-workers
(Kamei et al., 2006) showed, in cultured ECs and in zebrafish, that
lumen formation requires the intercellular fusion of intracellular
vesicles. However, other mechanisms, such as cavitation of
endothelial cords, are also possible (Lubarsky and Krasnow, 2003;
Iruela-Arispe and Davis, 2009; Blum et al., 2008; Kleaveland et
al., 2009).
Although different mechanisms might regulate lumen formation
in different types of vessels, the establishment of endothelial apical-
basal polarity is expected to be an absolute requirement for all of
them. In epithelial cells, apical-basal polarity is a prerequisite of
correct lumen organization (Martin-Belmonte and Mostov, 2008;
Jaffe et al., 2008). Since the partitioning defective (Par) polarity
complex is a key determinant of cell polarity (Goldstein and Macara,
2007), it is likely to be important in the organization of vascular
lumen. The specific localization and activity of this complex is
determined, at least in part, by the small GTPases Cdc42 (Martin-
Belmonte et al., 2007) and Rac (Chen and Macara, 2005), the Rac-
specific GEF Tiam (Mertens et al., 2005), the adaptor and regulatory
molecules Par3 and Par6, and the effector PKCz (Goldstein and
Macara, 2007; Iden and Collard, 2008). Cdc42 and Par3 have been
shown to regulate lumen formation of in three-dimensional (3D)
cultures of ECs (Koh et al., 2008). In addition, the small GTPase
CCM1 regulates vascular-lumen organization by
inducing endothelial polarity
Maria Grazia Lampugnani1,2,*, Fabrizio Orsenigo1, Noemi Rudini1, Luigi Maddaluno1, Gwénola Boulday3,
Francoise Chapon4 and Elisabetta Dejana1,5,*
1IFOM, FIRC Institute of Molecular Oncology Foundation, Via Adamello 16, 20139 Milan, Italy
2Mario Negri Institute of Pharmacology, 20156 Milan, Italy
3Université de Medeciné Paris Diderot - Paris 7, 75005 Paris, France
4Faculté de Mèdeciné, CHU Cote de Nacre, 14000 Caen, France
5Universita’ degli Studi di Milano, 20100 Milan, Italy
*Authors for correspondence (mariagrazia.lampugnani@ifom-ieo-campus.it; elisabetta.dejana@ifom-ieo-campus.it)
Accepted 20 January 2010
Journal of Cell Science 123, 1073-1080 
© 2010. Published by The Company of Biologists Ltd
doi:10.1242/jcs.059329
Summary
Little is known about the molecular mechanisms that regulate the organization of vascular lumen. In this paper we show that lumen
formation correlates with endothelial polarization. Adherens junctions (AJs) and VE-cadherin (VEC, encoded by CDH5) are required
for endothelial apicobasal polarity in vitro and during embryonic development. Silencing of CDH5 gene expression leads to abrogation
of endothelial polarity accompanied by strong alterations in lumenal structure. VEC co-distributes with members of the Par polarity
complex (Par3 and PKCz) and is needed for activation of PKCz. CCM1 is encoded by the CCM1 gene, which is mutated in 60% of
patients affected by cerebral cavernous malformation (CCM). The protein interacts with VEC and directs AJ organization and AJ
association with the polarity complex, both in cell-culture models and in human CCM1 lesions. Both VEC and CCM1 control Rap1
concentration at cell-cell junctions. We propose that VEC, CCM1 and Rap1 form a signaling complex. In the absence of any of these
proteins, AJs are dismantled, cell polarity is lost and vascular lumenal structure is severely altered.
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Rap1 controls lumen formation (Itoh et al., 2007) and
anteroposterior polarity (Gerard et al., 2007; Schwamborn and
Puschel, 2004). Excessive Rap1 activity leads to altered epithelial
acinar polarity (Itoh et al., 2007).
Furthermore, indirect data support the concept that AJs are
involved in regulating EC polarity and vascular lumen formation.
VE-cadherin (VEC) promotes endothelial cell-cell adhesion at AJs.
In the early murine embryo, a homozygous null mutation of the
gene encoding VEC (Cdh5) results in a reduction in lumenal size
of the aorta and of cardinal veins, although the lumens of other
vessels, such as cephalic vessels, become enlarged (Carmeliet et
al., 1999; Gory-Faure et al., 1999). Consistent with this data,
impaired lumen formation has been reported in zebrafish upon
knockdown of expression of the gene encoding VEC (Montero-
Balaguer et al., 2009). VEC can directly bind Par3, which is an
element of the polarity complex (Iden et al., 2006), and it is required
for junctional organization of Tiam (Lampugnani et al., 2002);
however, the actual pathway through which VEC regulates
endothelial polarity remains unclear.
Here, we present data indicating that VEC is needed for the
correct localization and to promote activation of the polarity
complex, which, in turn, establishes endothelial apical-basal polarity.
CCM1 stabilizes VEC at AJs and thus promotes the concentration
of the polarity complex at intercellular junctions. In the absence of
CCM1, apical-basal polarity of ECs is altered, and the size and
organization of vascular lumens is severely affected. These data
support the concept that CCM1 acts in concert with VEC and the
members of the polarity complex to modulate the vascular lumen
and offer a mechanistic explanation for the vascular malformations
observed in CCM disease.
Results
VEC regulates the formation of a polarized vascular lumen
HUVECs cultured in collagen gel rapidly organize into a network
of hollow structures (supplementary material Fig. S1) (Bayless and
Davis, 2002). Using podocalyxin (Podxl) and collagen IV (Coll IV)
as markers of the apical and basal surfaces, respectively (Horvat et
al., 1986; Hallmann et al., 2005), we observed that cells forming
these vascular-like structures were correctly polarized (Fig. 1A).
Knockdown of VEC protein expression using siRNA against CDH5
resulted in the formation of several small lumens lined with ECs
(supplementary material Fig. S1A) that were not regularly polarized
(Fig. 1A). This effect was not due to reduced expression of polarity
markers (supplementary material Fig. S2C). Consistently, in wild-
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Fig. 1. VEC is required for the formation of a
polarized endothelial lumen in vitro and in vivo.
(A) HUVECs after control siRNA in 3D collagen
gel form vascular structures with a central lumen
(L) lined with a monolayer with apical Podxl and
basal Coll IV (arrowheads and arrows, respectively,
boxed magnification). By contrast, CDH5-silenced
(VEC siRNA) ECs show abnormal lumen
maturation: the lumen is smaller, lacks apical Podxl
and intracellular vacuoles (V) that are typical of
early phases of lumen organization (Kamei et al.,
2006) are frequently present. Dashed line outlines
the lumen. Confocal sections at 24 hours. Scale
bars, 50 mm and 10 mm (in magnification).
(B) Confocal sections, of one dorsal aorta (DA) of
wild-type (wt) and VEC-null mouse embryos before
the onset of embryonic circulation (5 somites). The
lumen (L) in the wild-type embryo is wide and lined
with polarized ECs (Podxl apical and Coll IV basal,
arrowheads and arrows, red and green channels,
respectively, see magnification of boxed area). In
VEC-null embryos, the lumen is restricted and ECs
can be found inside forming a septum (asterisk),
which defines two lumens (L and L). Both Podxl
and Coll IV show ectopic basal and apical
distribution, arrowheads and arrows, respectively
(red and green channels, respectively, see
magnification of boxed areas). Dashed lines outline
the lumen. ECs are positive for PECAM (white
channel) and Podxl (red channel) in both wild-type
and VEC-null embryos (see magnification)
(Carmeliet at al., 1999). NT, neural tube. Scale bars:
50 mm and 10 mm (in magnification). (C) In 2D
culture, Podxl is often distributed to the basal
(arrowheads) instead of the apical surface (arrows)
in VEC-null ECs, or in sparse VEC-positive cells.
Confocal sections, z-axis. Scale bar: 25 mm.
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type embryos at the 5-somite stage, ECs in the dorsal aorta (Fig.
1B) were polarized and expressed Podxl and Coll IV at the apical
and basal sides, respectively. Conversely, in Cdh5-null embryos,
the vascular lumen was strongly altered and ECs were abnormally
polarized (Fig. 1B). In addition, the absence of VEC protein (in
VEC-null cells) or the lack of its engagement in cell-cell contacts
(in sparse VEC-positive cells, which were genetically modified to
express human CDH5) impaired the apical distribution of Podxl in
2D culture (Fig. 1C).
We then tested whether VEC could determine the localization
and activate the Par polarity complex that has a crucial role in the
establishment and maintenance of apical-basal polarity (Goldstein
and Macara, 2007; Iden and Collard, 2008). We first observed that
Par3, phosphorylated Thr410 PKCz and Tiam (all of which are
components of the Par polarity complex) required the presence of
VEC for their correct localization at cell-cell junctions
(supplementary material Fig. S3A). In addition, phosphorylated
PKCz expression levels were higher in ECs expressing VEC than
in VEC-null cells (Fig. 4C). Higher levels of GTP-bound Rac and
Cdc42 were also observed in control cells than in VEC-null cells
(supplementary material Fig. S3B). Finally, the knockdown (KD)
of components of the polarity complex, Tiam and Par3, inhibited
lumen formation in HUVECs (supplementary material Fig. S1A),
but did not affect the expression and distribution of VEC
(supplementary material Fig. S2B and M.G.L., unpublished results),
suggesting a role for these molecules as effectors, rather than
activators, of the VEC complex.
CCM1 acts in concert with VEC to establish and maintain
correct EC polarity and vascular lumen
When the expression of CCM1 was downregulated in HUVECs by
siRNA (which knocked down CCM1 protein levels by some 70%,
independently of the oligos used, supplementary material Fig. S2A),
the lumen of vascular-like structures in 3D collagen gel was highly
abnormal, both at early and late stages of culture (Fig. 2A;
supplementary material Fig. S1A). CCM1-knockdown cells lining
the lumen were poorly polarized. In several regions, Coll IV
presented apical distribution (Fig. 2A) and, although the expression
levels of Podxl were not reduced by CCM1 gene silencing
(supplementary material Fig. S2C), it did not show the normal
distinct apical polarization (Fig. 2A).
Podxl was also depolarized in the endothelium of CCM lesions
from a patient with mutated CCM1 (Fig. 2B). In the areas of tortuous,
lace-like vessels, Podxl was often lacking from the lumenal surface
and was instead concentrated at the basal aspect of ECs. Podxl
appeared normally polarized in peri-lesion vessels (Fig. 2B).
CCM1 has been shown to associate indirectly with AJs
(Glading et al., 2007). As reported above, VEC is important in
endothelial polarization and lumen formation. Furthermore, the
3D phenotype observed in CDH5-knockdown cells resembles that
of CCM1-knockdown cells. CCM1 might, therefore, act in
concert with VEC to promote cell polarity and regular lumen
formation. As reported in Fig. 3A, we found that CCM1
associated with VEC. This was further supported by the
observation that CCM1 was lost from junctions when CDH5 gene
Fig. 2. Endothelial lumen and polarity are
abnormal in CCM1-silenced HUVECs and in
human CCM1 vascular lesions. (A) HUVEC
vascular structures in 3D culture. At early stages (12
hours) a single central lumen (L) is formed with
control siRNA, whereas two eccentric lumens (L and
L) are typically observed with CCM1 siRNA. At
later stages (24 hours), CCM1-silenced ECs form an
irregular lumen with cell aggregates at the wall.
Podxl (arrowheads) is cytoplasmic or ablumenal
whereas collagen IV appears to be lumenal (arrows)
(see boxed magnification). Dashed lines outline the
lumen. Scale bars: 50 mm (left), 50 mm (central) and
10 mm (magnified areas). (B) Vascular lesion in a
patient with heterozygous mutation of CCM1. In
vessels at the periphery of the lesion (Peri-lesion)
the lumen (L) is correctly polarized, with apical
Podxl (arrowheads). By contrast, within the lesion,
tortuous and multiple lumens (L) often lack apical
Podxl, which appears to be basal or displays a
diffuse pattern of expression (arrowheads). Dashed
lines outline the lumens. Scale bars: 115 mm (top),
60 mm (bottom left) and 10 mm (bottom right).
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expression was silenced (Fig. 3B), indicating that VEC is needed
for CCM1 organization at AJs.
We then examined the effects of CCM1 on junction organization
and localization of components of the polarity complex. Silencing
of CCM1 expression strongly affected junctional clustering of VEC
and b-catenin. Both proteins relocalized from lateral junctions
towards large areas flanking the junctions (Fig. 3D). VEC and b-
catenin were often distributed toward the apical membrane (Fig.
3C, top panels, z-axis) and toward the basal aspect of HUVECs in
3D culture (Fig. 3C, bottom panels). Similarly to VEC, junctional
staining of components of the Par polarity complex (Par3 and
phosphorylated PKCz and Tiam) was strongly altered after
knockdown of CCM1 (Fig. 4A). Comparable effects were observed
using RNA-silencing oligos that targeted independent sequences of
CCM1 mRNA (our unpublished results), that were as effective at
silencing the expression of CCM1 as the oligos used for experiments
described in Figs 3 and 4 (see also supplementary material Fig.
S2A). Most importantly, ablation of the Ccm1 gene in ECs isolated
from Ccm1 fl/fl mice produced effects comparable with those
described after siRNA treatment (Fig. 3E, Fig. 4B, and
supplementary material Fig. S2A).
Together, these data show that VEC and CCM1 interact at AJs,
and that both are required for junctional localization of the polarity
complex. However, VEC was needed for phosphorylation of PKCz
at Thr410 (Fig. 4C), whereas CCM1 controlled the junctional
localization of this molecule. Analysis of lesions from a patient
with mutated CCM1 confirmed that both VEC (Fig. 3F) and
phosphorylated PKCz (Fig. 4D) are strongly delocalized from
endothelial junctions in these areas: their focal junctional distribution
is lost, but is maintained in the endothelium of peri-lesion vessels.
Finally, we observed that Rap1 was also important in EC
polarity. Indeed, localization of the components of the Par polarity
complex phosphorylated PKCz (Fig. 5A), as well as Par3 and Tiam
(supplementary material Fig. S3C) were strongly reduced at
junctions upon treatment of ECs with RAP1B siRNA. Consistent
with this observation, RAP1B siRNA altered endothelial cell polarity
and lumen formation (Fig. 5C). Dismantling AJs by silencing either
CCM1 (Fig. 5D) or CDH5 (Gore et al., 2008) led to loss of Rap1b
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Fig. 3. VEC and CCM1 form a complex and
reciprocally regulate their localization to
endothelial cell-cell junctions both in cultured
ECs and in human CCM1 vascular lesions.
(A) VEC and CCM1 are coimmunoprecipitated
in VEC-positive ECs. The complex is detected
after immunoprecipitation (IP) with antibodies
against CCM1. IP with irrelevant
immunoglobulins (IgG) and IP-input extracts
(Total) were also probed. The blots are
representative of three independent experiments.
(B) In CDH5-silenced (VEC siRNA) HUVECs,
CCM1 disappears from cell-cell contacts
(compare with arrowheads in control siRNA).
Scale bar: 20 mm. (C,D) In Ccm1-silenced VEC-
positive cells (2D culture, C top panels and D)
or CCM1-silenced HUVECs (3D culture; C,
bottom panels) VEC and b-catenin expression is
lost at junctions and the proteins are
redistributed apically or basally (C, arrows and
arrowheads). Four independent oligos and smart
pooled oligo against CCM1 and Ccm1 were
used in silencing experiments with comparable
results (see supplementary material Fig. S2).
(E) Lung-derived ECs isolated from Ccm1 fl/fl
mice and treated with TAT-Cre (CCM1
fl/fl+Cre) to inactivate Ccm1 gene in vitro (see
supplementary material Fig. S2) show diffuse
VEC and b-catenin expression patterns that are
similar to those observed with Ccm1 siRNA
(arrows in D). (F) Vascular lesion in a patient
with heterozygous mutation of CCM1 gene.
VEC appears to be diffusely expressed outside
the junctions in ECs of the lesion (arrowheads,
magnification of boxed area). By contrast, in
vessels at the periphery of the lesion (Peri-
lesion) VEC is focally concentrated at cell-cell
contacts in ECs (arrowheads, magnification of
boxed area). The dashed lines outline the
lumens (L). Scale bars: 50 mm (C), 20 mm (D,E);
50 mm and 10 mm (F).
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from intercellular contacts and to its relocalization to focal contacts,
as previously reported in other cell types (Balzac et al., 2005). The
active form of Rap, Rap1 G12V, was observed at junctions in a
CCM1-dependent manner (Fig. 5E), although knockdown of VEC
abrogated Rap1b activation (Fig. 5B).
Discussion
In the present paper, we have shown that VEC and CCM1 form a
complex and act in concert to determine the correct junctional
localization of the Par polarity complex that is required for endothelial
polarization and formation of vascular lumen. This conclusion is
supported by the observation that cadherin proteins might act as
scaffolds for the construction of polarized structures (Capaldo and
Macara, 2007). We did not perform detailed studies on the molecular
basis of the interaction of CCM1 with VEC, but Glading and
colleagues (Glading et al., 2007) reported that CCM1 could bind b-
catenin directly. It is therefore likely that CCM1 associates indirectly
with VEC, via binding to b-catenin. These authors also found that
CCM1 is an effector of Rap1. The active state of this small GTPase
induces a conformational change in CCM1 that is required for CCM1
binding to b-catenin. Rap1, which also concentrates at intercellular
contacts, is known to stabilize AJs, thus reducing vascular fragility
(Kooistra et al., 2005). CCM1 has therefore been proposed to act
downstream of Rap1 in the stabilization of AJs. We show here that
Rap1b, which is recruited to the complex formed by VEC and CCM1,
contributes to polarization and lumen formation by stabilizing AJs.
The need for VEC homophilic interactions to permit Rap1b activity
has been previously reported. Clustering of VEC would allow
junctional localization of guanosine-exchange factors such as C3G
or PDZ-GEF to promote local activation of Rap1 (Kooistra et al.,
2007; Sakurai et al., 2006). VEC and CCM1 exert a different type
of control on PKCz, the effector component of the polarity complex.
Both VEC and CCM1 direct junctional localization of PKCz.
However, only VEC is required for the phosphorylation of PKCz at
Thr410, which is needed for expression of the catalytic activity of
the enzyme (Standaert et al., 1999). Nevertheless, segregation of
PKCz is fundamental to allow phosphorylation of the correct
molecular targets in the appropriate subcellular compartment (Wirtz-
Peitz et al., 2008). Loss of segregation of the Par polarity complex
and PKCz can have a strong impact on their signaling and functional
outcome (Goldstein and Macara, 2007; Martin-Belmonte et al., 2007).
This has recently been shown in vivo during the organization of
tubular structures in the morphogenesis of the mammary gland
(McCaffrey and Macara, 2009).
Fig. 4. CCM1 is required for junctional
localization of the components of the polarity
complex Tiam, Par3 and phosphorylated PKCz
in cultured ECs and in human CCM1 vascular
lesion. (A,B) Junctional staining of Tiam, Par3 and
phosphorylated PKCz, in both Ccm1-silenced
VEC-positive cells and in Ccm1 fl/fl+Cre cells,
appears convoluted and fragmented (arrowheads).
This pattern is reminiscent of VEC and b-catenin
distribution in Ccm1-silenced ECs (Fig. 3D,E).
Scale bar: 20 mm. (C) Phosphorylation of PKCz at
Thr410 (p-PKCz) is downregulated by 40% and
80%, respectively, in CDH5-silenced HUVECs and
in VEC-null cells. Phosphorylation of PKCz is not
modified after CCM1 or Ccm1 siRNA treatment.
Data shown are representative of three independent
experiments. Vertical bars indicate that the bands,
from the same blot, do not come from contiguous
lanes. (D) Brain vascular lesion of a patient with
heterozygous mutation of CCM1 gene.
Phosphorylated PKCz expression is diffuse over
large areas in the endothelium of the vascular
mulberry lesion (arrowheads, magnification of
boxed area). It is instead concentrated to
interendothelial junctions in peri-lesion vessels
(arrowheads, magnification of boxed area). Scale
bars: 50 mm and 10 mm (in magnifications).
Asterisks indicate the nuclei of ECs lining the
lumen (dashed line).
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The mechanism through which VEC influences endothelial
polarity has not been investigated, as yet. In epithelial cells,
cadherins promote the organization of TJs. In turn, TJs determine
cell polarity, and act as a barrier to the redistribution of proteins
and lipids between the apical and basolateral surfaces (Martin-
Belmonte et al., 2007; Nejsum and Nelson, 2007; Mertens et al.,
2006). However, early phases of epithelial polarization occur also
in the absence of TJs (Umeda et al., 2006; Qin et al., 2005). TJs
are either absent or very poorly organized in cultured ECs or in
vascular endothelium at early phases of embryo development
(Liebner et al., 2008; Carmeliet et al., 1999), which are the
experimental models used in the present study. VEC and AJs could
therefore serve to control early phases of polarity and lumen
formation in the absence of TJs (Yu et al., 2005). As both
phosphorylation at Thr410 (Standaert et al., 1999), and GTP-Cdc42
(Martin-Belmonte et al., 2007) or GTP-Rac (Chen and Macara,
2005; Mertens et al., 2005) are required for full activation and correct
positioning of PKCz, our data strongly suggest that VEC induces
the early steps of cell polarization by permitting the correct
localization and activation of the polarity complex. However, since
junctional clustering of VEC precedes and triggers TJ organization
(Taddei et al., 2008), it is possible that when junctions are fully
stabilized, the polarity complex re-localizes from AJs to TJs
(Mertens et al., 2006) to maintain cell polarity (Capaldo and Macara,
2007).
CCM1 can form a complex with CCM2 and CCM3 (Zawistowski
et al., 2005; Voss et al., 2007). Although CCM proteins are
structurally distinct, gene inactivation of any one of them leads to
a comparable clinical outcome (Plummer et al., 2005), suggesting
that these proteins act in concert to promote similar cell functions.
CCM2 limits Rho activation and, as a consequence, reduces
endothelial cell contractility and vascular permeability (Whitehead
et al., 2009). The organization of the actin cytoskeleton might also
be implicated in cell polarity (Iden and Collard, 2008). It is therefore
possible that CCM2 also contributes indirectly to the establishment
of cell polarity through a reshaping of the cell cytoskeleton
(Whitehead et al., 2009).
In conclusion, our data show that the presence of VEC and CCM1
is needed at AJs to establish cell polarity and lumen formation.
These effects are mediated by recruitment and activation of the
polarity complex and Rap1b. In the absence of any of these proteins,
AJs are not correctly organized, cell polarity is lost and vascular
lumen formation is severely altered. These observations suggest that
the various proteins implicated in inducing cell polarity do not
function independently, but interact with one another in a signaling
network.
Materials and Methods
Cells and 2D culture
Human umbilical vein endothelial (HUVEC) cells and murine endothelial cells
genetically ablated for Cdh5 (VEC-null) or genetically modified to express human
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Fig. 5. Rap1b contributes to the polarizing
activity of VEC and CCM1. (A) Rap1b regulates
the junctional localization of phosphorylated PKCz.
In RAP1B-silenced HUVECs, phosphorylated
PKCz loses its linear junctional expression pattern
(arrowheads), which instead becomes fragmented
(arrows). Scale bar: 20 mm. (B) Rap1b requires
VEC expression for its activation. Pull-down of
GTP-Rap1was followed by western blotting for
Rap1b. Two additional experiments gave
comparable results. (C) RAP1B-silenced HUVECs
show abnormal lumen (L) maturation (24 hours).
Podxl and Coll IV apical or basal localization,
respectively, is lost (arrowheads and arrows). The
dashed lines outline the lumen. Scale bars: 50 mm
and 10 mm (magnifications). (D) Rap1 disappears
from cell-cell contacts in Ccm1 silenced or Ccm1
fl/fl+Cre cells and often concentrates at focal
contacts (arrows and arrowheads). (E) Active Rap1
(HA-Rap1 GV12) concentrates to cell-cell junctions
with VEC, in control cells (Ccm1 fl/fl) (arrows).
The junctional localization is strongly reduced or
lost (arrows) in parallel with diffusion of VEC in
Ccm1-silenced (Ccm1 fl/fl+Cre) ECs.
Immunofluorescence staining with an antibody
against the HA tag present in Rap1 GV12. Scale
bar: 20 mm (D,E).Jo
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CDH5 (VEC-positive) were obtained and cultured as described (Lampugnani et al.,
2002). Lung endothelial cells from a mouse (57/BL/6N) in which exons 4-5 of Ccm1
gene are flanked by loxP sites (Ccm1 fl/fl) (produced by Artemis Taconis, Cologne,
Germany) were isolated and immortalized as described (Balconi et al., 2000). Deletion
of exons 4-5 by Cre-mediated recombination produces loss of function by removing
the exons encoding part of the p53-like DNA-binding domain and generating a frame-
shift in downstream exons. Ccm1 was inactivated treating cells in culture with TAT-
Cre recombinase (Liebner et al., 2008). For TAT-Cre treatment: Ccm1 fl/fl ECs were
treated with 100 mg/ml TAT-Cre for 60 minutes in HyClone ADCF-MAb medium
(Thermo Scientific) and with 100 mM chloroquine for further 60 minutes (Wadia et
al., 2004). Cells (Ccm1 fl/fl + Cre) were used for experiments after at least two in
vitro passages from TAT-Cre treatment.
For two-dimensional (2D) cultures, cells were seeded in 35 mm Petri dishes or in
0.2 cm2 wells created with flexiPERM frames (Greiner Bio-One, Germany) on
polystyrene cell culture slides (NUNC, Thermo Fisher, Denmark). In both cases, the
coating was with gelatin (Difco Gelatin, BD, 0.1% for murine cells and 1.5% for
HUVECs). Cells were cultured for 72-96 hours. The splitting ratio was such that
confluence was reached overnight after seeding. HA-Rap1 G12V (a gift from Giorgio
Scita, IFOM, Milano, Italy) and HA-Rap GAP (a gift from Johannes Bos, University
Medical Center Utrecht, Utrecht, The Netherlands) were introduced in lentiviral
plasmids to produce lentiviral vectors, as described (Taddei et al., 2008).
RNA interference
For small RNA interference (siRNA) the following oligos were used: anti-CCM1,
human-specific (pool, L-003825-00) (ON-TARGET plus SMART pool, Dharmacon);
murine-specific oligo 2 (KRIT1MSS234457) and oligo 4 (KRIT1MSS294386);
human- and murine-specific oligo 3 (KRIT1MSS234455) were all stealth oligo,
Invitrogen. Anti-humanVE-cadherin: (L-003641-00); Anti-Rap1b: human-specific
(L-010364-00) and murine-specific (L-062638-01); anti-human Tiam (L-003932-
01); anti-human Par3 (L-015602-00) were all ON-TARGET plus SMART
pool, Dharmacon. Control oligos were ON-TARGET plus siControl (D-001810-10,
Dharmacon) and Medium G-C control oligo (12935-300, Invitrogen) when
Dharmacon SMART pool or Invitrogen oligos were used, respectively. For oligo
transfection, cells were seeded at a density of 104/cm2. 20 hours later, they were
transfected with 40 nM of small interfering oligo for 5 hours in Optimem (Invitrogen)
using Lipofectamine 2000 (Invitrogen). The effects of silencing were tested 72-96
hours after transfection.
Antibodies
For immunofluorescence (IF), western blot (WB) and immunoprecipitation, the
following antibodies were used: VE-cadherin (C-19, sc-6458, goat, Santa Cruz), b-
catenin (mouse, BD Transduction Laboratories), CCM1 (residues 1-207 of the human
sequence and crossreacting with mouse protein, rabbit, gifts from Elisabeth Tournier-
Lasserve, Université de Médicine Paris Diderot, Paris, France and Francesco Retta,
University of Torino, Torino, Italy) and (KRIT1, K-16, sc-23997, goat, Santa Cruz),
phosphorylated PKCz (rabbit, Cell Signaling), total a-PKCz (C-20, sc-216, rabbit,
Santa Cruz), Rap1 (121, sc-65, rabbit, Santa Cruz, for IF), Rap1b (rabbit, Cell
Signaling, for WB), Tiam 1 (C-16, sc-872, rabbit, Santa Cruz), Podxl (murine-specific
and human-specific, R&D), Coll IV (murine-specific and human-specific, AbD
Serotec), Par3 (rabbit, Millipore), Pecam (clone 13.3, rat anti-mouse), Flag, (M2,
mouse, Sigma), rac (mouse, BD Transduction Laboratories), cdc42 (rabbit, Cell
Signaling), HA (clone 11, mouse, Covance). For in vivo treatment and three-
dimensional (3D) culture, a murine anti-human VEC (clone BV9, home made), which
inactivates VEC (Corada et al., 2001) was used as specified in supplementary material
Fig. S1. Secondary antibodies for IF were donkey antibodies to the appropriate species
conjugated with Alexa Fluor 488, 555 or 647 (Molecular Probes).
Immunofluorescence microscopy
Cells in 2D culture were fixed either with 3% picric-acid-paraformaldehyde (PAF)
in PBS (followed by permeabilization with 0.5% Triton X-100 for 5 minutes) or with
1% PAF in triethanolamine, pH 7.5, containing 0.1% Triton X-100 and 0.1% NP-
40. Blocking (1 hour), primary (1 hour) and secondary (50 minutes) antibodies were
in PBS with 1% BSA or 0.7% fish skin gelatin (FSG). For some antibodies (Rap1,
phosphorylated PKCz), the first antibody was incubated overnight at 4°C. Primary
antibody contained also 5% donkey serum, because all the secondary antibodies used
were donkey IgG.
3D cultures were fixed with 3% PAF for 35 minutes, quenched with 75 mM
NH4Cl and 20 mM glycine in PBS, pH 8, for 10 minutes and blocked with 0.7%
FSG and 0.3% Triton X-100 PBS (blocking buffer) for 30 minutes. Primary and
secondary antibodies were incubated overnight at 4°C. Primary antibody contained
5% donkey serum. Washes in blocking buffer were performed over the course of
a day at room temperature. Nuclei were stained with DAPI for 30 minutes, and
samples post-fixed with 3% PAF for 2 minutes. Embryos were stained in whole
mount essentially as for 3D cultures (see above). They were then included in low-
melting-point agarose and cut in 100-mm-thick slides using a vibratome. Slides
were mounted within two coverslips to allow confocal examination on the two
sides of the section.
Paraffin sections were deparaffinized according to standard procedures and stained
as 3D cultures, except that the secondary antibody was for 1 hour at room temperature.
Samples were mounted in Vectashield containing DAPI. 2D culture images were
obtained by epifluorescence and confocal microscopy. Images of 3D cultures, embryo
sections and tissue sections were obtained by confocal microscopy. Figures were
assembled using Adobe Photoshop and Adobe Illustrator.
3D culture in collagen gels
HUVECs were cultured in 3D collagen gel as described (Bayless and Davis, 2002).
Final cell concentration in collagen (3.5 mg/ml final concentration collagen type1
from rat tail, High Concentration, BD Biosciences) was 5105 cells/ml. Culture
medium was 199 with 1% FCS, Insulin-Transferrin-Selenium supplement (Life
Technologies), 50 ng/ml PMA, 50 mg/ml ascorbic acid, 40 ng/ml VEGF, 40 ng/ml
bFGF. When indicated, 8-pCPT-2OMe-cAMP (007, 100 mM, Biolog) was added
to the culture medium. For experiments with siRNA-silenced cells, cells were
transfected with RNA oligos in 50 cm2 Petri dishes 48 hours before the beginning
of 3D culture. 50 ml cell suspension in collagen was used for each well of a 96-
well plate for transmission microscopy. For confocal microscopy, 190 ml cell
suspension in collagen was used for each microwell (m-slide 80826, Ibidi,
Germany).
Isolation of mouse embryos
Mouse embryos were dissected from VEC heterozygous females after breeding with
VEC heterozygous males). Dissection was at day 8-8.5 of pregnancy. A description
of the production and features of this strain is described (Carmeliet et al., 1999).
Embryos were fixed in 4% PAF overnight before staining as described below.
Pull down of GTP-bound small GTPases
GTP-bound Rac and cdc42 were pulled-down as described (Lampugnani et al., 2002).
The pull-down sample was then loaded in separate lanes and anti-Rac and anti-cdc42
antibodies were used in western blots to specifically recognize each GTPase. Rap-
GTP was separated using a GST-RalGDS-RBD probe as described (Cera et al., 2009).
Specific antibodies to Rap1b were used in western blotting to recognize this isoform
of Rap1 that is the most abundant in ECs (Gore et al., 2008).
Western blot and immunoprecipitation
Total extracts were obtained using 2 Laemmli sample buffer. After 10 minutes
of boiling, protein content was quantified (BCA, Pierce). Samples were then
reduced by adding DTT (50 mM). Extraction for immunoprecipitation was as
described (Rudini et al., 2008). Bands on films revealed through ECL were
quantified through ImageJ (freely available at the NIH website). Several exposure
times were used for each blot and values in the linear range of detection were
used for quantification.
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